Marpai (MRAI) Competitors $1.39 +0.01 (+0.72%) As of 08/29/2025 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock MRAI vs. BNR, BDSX, ATPC, KDLY, PIII, BMGL, CCM, MGRX, BRTX, and BGLCShould you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Burning Rock Biotech (BNR), Biodesix (BDSX), Agape ATP (ATPC), Kindly MD (KDLY), P3 Health Partners (PIII), Basel Medical Group (BMGL), Concord Medical Services (CCM), Mangoceuticals (MGRX), Biorestorative Therapies (BRTX), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry. Marpai vs. Its Competitors Burning Rock Biotech Biodesix Agape ATP Kindly MD P3 Health Partners Basel Medical Group Concord Medical Services Mangoceuticals Biorestorative Therapies BioNexus Gene Lab Burning Rock Biotech (NASDAQ:BNR) and Marpai (NASDAQ:MRAI) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Do insiders & institutionals believe in BNR or MRAI? 30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 49.8% of Marpai shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by insiders. Comparatively, 46.1% of Marpai shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more risk and volatility, BNR or MRAI? Burning Rock Biotech has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Comparatively, Marpai has a beta of 4.66, meaning that its share price is 366% more volatile than the S&P 500. Does the media favor BNR or MRAI? In the previous week, Marpai had 1 more articles in the media than Burning Rock Biotech. MarketBeat recorded 3 mentions for Marpai and 2 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 1.62 beat Marpai's score of -0.19 indicating that Burning Rock Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Burning Rock Biotech 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Marpai 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable earnings and valuation, BNR or MRAI? Marpai has lower revenue, but higher earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBurning Rock Biotech$523.28M0.18-$47.49M-$1.89-4.53Marpai$34.87M0.69-$28.75M-$0.87-1.60 Is BNR or MRAI more profitable? Burning Rock Biotech has a net margin of -45.41% compared to Marpai's net margin of -85.70%. Marpai's return on equity of 0.00% beat Burning Rock Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Burning Rock Biotech-45.41% -38.33% -25.34% Marpai -85.70%N/A -100.23% SummaryMarpai beats Burning Rock Biotech on 9 of the 13 factors compared between the two stocks. Get Marpai News Delivered to You Automatically Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MRAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRAI vs. The Competition Export to ExcelMetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ ExchangeMarket Cap$24.01M$93.09M$26.22B$9.74BDividend YieldN/AN/A2.74%4.48%P/E Ratio-0.530.8227.3726.59Price / Sales0.690.481,120.00159.07Price / CashN/A2.8025.6328.92Price / Book-0.810.176.856.08Net Income-$28.75M$43.11M$197.83M$265.93M7 Day Performance-4.14%-23.59%0.48%0.36%1 Month Performance17.80%37.86%9.28%5.58%1 Year Performance152.73%30.91%44.19%19.67% Marpai Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRAIMarpaiN/A$1.39+0.7%N/A+152.7%$24.01M$34.87M-0.53150News CoverageGap DownBNRBurning Rock Biotech0.809 of 5 stars$8.91+3.6%N/A+61.5%$92.55M$70.67M-4.711,390Positive NewsBDSXBiodesix3.4912 of 5 stars$0.47-5.0%$1.75+276.3%-78.2%$71.78M$71.32M-1.60220Positive NewsATPCAgape ATP0.1579 of 5 stars$1.35+1.9%N/A-48.6%$66.26M$1.45M-3.2940KDLYKindly MDN/A$9.17-9.5%N/A+353.3%$55.22M$2.47M-11.91N/AGap DownPIIIP3 Health Partners2.1725 of 5 stars$7.99+8.1%$16.25+103.4%-67.2%$53.11M$1.46B-0.17500BMGLBasel Medical GroupN/A$2.02+1.5%N/AN/A$36.73M$10.00M0.0036Positive NewsCCMConcord Medical Services0.4246 of 5 stars$5.67+3.7%N/A-19.5%$24.06M$52.60M0.00970Gap DownMGRXMangoceuticals0.765 of 5 stars$1.87+12.5%N/A-95.6%$17.51M$516.03K-0.483Positive NewsHigh Trading VolumeBRTXBiorestorative Therapies2.7031 of 5 stars$1.53+1.3%N/A+12.2%$12.05M$400K-1.207Positive NewsBGLCBioNexus Gene Lab0.1884 of 5 stars$5.59-0.9%N/A+28.9%$10.13M$9.51M0.0030Positive News Related Companies and Tools Related Companies Burning Rock Biotech Competitors Biodesix Competitors Agape ATP Competitors Kindly MD Competitors P3 Health Partners Competitors Basel Medical Group Competitors Concord Medical Services Competitors Mangoceuticals Competitors Biorestorative Therapies Competitors BioNexus Gene Lab Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MRAI) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersNew Banking Law #1582 Could Unlock $21 Trillion for AmericansDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
